Phenomix Corporation · San Diego, CA United States
Company Description
Phone: 858-731-5200
Fax: 858-731-5225
View Phenomix Corporation Locations On A US Map
This link will open in a new window
Phenomix hopes to create a pharmaceutical phenomenon by investigating and discovering new treatments for immune system ailments and metabolic diseases. The drug development company's lead product candidate dutogliptin is an oral-dose treatment aiming to stabilize glucose levels in patients with Type 2 diabetes. Other pipeline candidates target infectious and autoimmune diseases, including hepatitis C and certain types of cancer. The biotechnology firm's drug candidates focus on inhibiting complex proteins (enzymes) that promote disease within the body. The company is owned by a number of private investors. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Phenomix Corporation Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $4.5 |
| Employees | 40 |
Phenomix Corporation Executives
14 executives listed for Phenomix Corporation's San Diego, CA location.
| Title | Name & Bio | Contact |
| CEO and Director | Laura Shawver | Network |
| President | Julie Cherrington | Network |
| VP Finance | Brian Baker | Network |
Competition
Competitive Landscape for Phenomix Corporation
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Phenomix Corporation Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
